Article Versions Notes

Elfiky AMI, Hageman IL, Becker MAJ, Verhoeff J, Li Yim AYF, Joustra VW, Mulders L, Fung I, Rioja I, Prinjha RK, et al. A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease. Cells. 2022; 11(18):2846. https://doi.org/10.3390/cells11182846

Elfiky, Ahmed M. I., Ishtu L. Hageman, Marte A. J. Becker, Jan Verhoeff, Andrew Y. F. Li Yim, Vincent W. Joustra, Lieven Mulders, Ivan Fung, Inmaculada Rioja, Rab K. Prinjha, and et al. 2022. "A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease" Cells 11, no. 18: 2846. https://doi.org/10.3390/cells11182846

Elfiky, A. M. I., Hageman, I. L., Becker, M. A. J., Verhoeff, J., Li Yim, A. Y. F., Joustra, V. W., Mulders, L., Fung, I., Rioja, I., Prinjha, R. K., Smithers, N. N., Furze, R. C., Mander, P. K., Bell, M. J., Buskens, C. J., D’Haens, G. R., Wildenberg, M. E., & de Jonge, W. J. (2022). A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease. Cells, 11(18), 2846. https://doi.org/10.3390/cells11182846